Wencyk P - Search Results

1

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

Pinder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, Robertson JF, Blamey RW, Ellis IO. Pinder SE, et al. Among authors: wencyk p. Br J Cancer. 1995 Jan;71(1):146-9. doi: 10.1038/bjc.1995.30. Br J Cancer. 1995. PMID: 7819031 Free PMC article.

2

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.

Travis A, Pinder SE, Robertson JF, Bell JA, Wencyk P, Gullick WJ, Nicholson RI, Poller DN, Blamey RW, Elston CW, Ellis IO. Travis A, et al. Among authors: wencyk p. Br J Cancer. 1996 Jul;74(2):229-33. doi: 10.1038/bjc.1996.342. Br J Cancer. 1996. PMID: 8688326 Free PMC article.

3

The assessment of multiple variables on breast carcinoma fine needle aspiration (FNA) cytology specimens: method, preliminary results and prognostic associations.

Pinder SE, Wencyk PM, Naylor HE, Bell JA, Elston CW, Robertson JF, Blamey RW, Ellis IO. Pinder SE, et al. Among authors: wencyk pm. Cytopathology. 1995 Oct;6(5):316-24. doi: 10.1111/j.1365-2303.1995.tb00577.x. Cytopathology. 1995. PMID: 8785369

4

An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.

Gonzalez MA, Pinder SE, Wencyk PM, Bell JA, Elston CW, Nicholson RI, Robertson JF, Blamey RW, Ellis IO. Gonzalez MA, et al. Among authors: wencyk pm. J Pathol. 1999 Apr;187(5):523-9. doi: 10.1002/(SICI)1096-9896(199904)187:5<523::AID-PATH296>3.0.CO;2-3. J Pathol. 1999. PMID: 10398116

5

E-cadherin as a prognostic indicator in primary breast cancer.

Parker C, Rampaul RS, Pinder SE, Bell JA, Wencyk PM, Blamey RW, Nicholson RI, Robertson JF. Parker C, et al. Among authors: wencyk pm. Br J Cancer. 2001 Dec 14;85(12):1958-63. doi: 10.1054/bjoc.2001.2178. Br J Cancer. 2001. PMID: 11747340 Free PMC article.

6

Neuroendocrine differentiation and prognosis in breast adenocarcinoma.

Miremadi A, Pinder SE, Lee AH, Bell JA, Paish EC, Wencyk P, Elston CW, Nicholson RI, Blamey RW, Robertson JF, Ellis IO. Miremadi A, et al. Among authors: wencyk p. Histopathology. 2002 Mar;40(3):215-22. doi: 10.1046/j.1365-2559.2002.01336.x. Histopathology. 2002. PMID: 11895486

7

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.

Dowsett M, Bartlett J, Ellis IO, Salter J, Hills M, Mallon E, Watters AD, Cooke T, Paish C, Wencyk PM, Pinder SE. Dowsett M, et al. Among authors: wencyk pm. J Pathol. 2003 Apr;199(4):418-23. doi: 10.1002/path.1313. J Pathol. 2003. PMID: 12635131

8

Prognostic significance of BRCA1 expression in sporadic breast carcinomas.

Lambie H, Miremadi A, Pinder SE, Bell JA, Wencyk P, Paish EC, Macmillan RD, Ellis IO. Lambie H, et al. Among authors: wencyk p. J Pathol. 2003 Jun;200(2):207-13. doi: 10.1002/path.1348. J Pathol. 2003. PMID: 12754741

9

Expression of p27kip1 in breast cancer and its prognostic significance.

Barnes A, Pinder SE, Bell JA, Paish EC, Wencyk PM, Robertson JF, Elston CW, Ellis IO. Barnes A, et al. Among authors: wencyk pm. J Pathol. 2003 Nov;201(3):451-9. doi: 10.1002/path.1464. J Pathol. 2003. PMID: 14595757

10

Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value?

Rampaul RS, Pinder SE, Wencyk PM, Nicholson RI, Blamey RW, Robertson JF, Ellis IO. Rampaul RS, et al. Among authors: wencyk pm. Clin Cancer Res. 2004 Apr 1;10(7):2578. Clin Cancer Res. 2004. PMID: 15073139 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page